Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Versus Topical Levofloxacin for Chronic Rhinosinusitis Exacerbations
NCT01988779Phase 3Completed
- Sponsor
- University of Rochester
- Start
- Oct 2013
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levofloxacin in chronic rhinosinusitis (CRS), sponsored by University of Rochester. Started Oct 2013; status: completed.
02
Drugs
levofloxacin
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT01988779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01988779.